Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.
Precision BioSciences (DTIL) announced initial results from the first administration of PBGENE-HBV in cohort 1, the lowest dose level of the ...
Only one out of 24 patients with hepatitis had an elevated INR (1.49), and it was probably attributable to a more severe clinical course with bacterial superinfection of skin lesions and suspected ...